Research Article
Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
Table 1
Patient demographic information.
| | Study populations | | | | Total () | Bladder cancer tissue specimen () | Matched bladder cancer and normal adjacent tissues () |
| | Age (years): mean (range) | 68 (28–90) | 67 (28–90) | 69 (53–90) |
| | Gender | | | | | Male | 35 | 35 | 12 | | Female | 13 | 13 | 4 |
| | Histologic cell type | | | | | Transitional cell carcinoma | 41 | 41 | 12 | | Small cell carcinoma | 4 | 4 | 1 | | Squamous cell carcinoma | 3 | 3 | 3 |
| | T stage | | | | | T1 | 9 | 9 | 2 | | T2 | 11 | 11 | 3 | | T3 | 18 | 18 | 8 | | T4 | 6 | 6 | 1 | | Tx | 4 | 4 | 4 |
| | N stage | | | | | N0 | 27 | 27 | 9 | | N1 | 8 | 8 | 2 | | N2 | 8 | 8 | 3 | | Nx | 5 | 5 | 2 |
|
|
